Universal Health International Group Holding (2211) Stock Overview
An investment holding company, distributes and retails drugs and other pharmaceutical products in the northeastern region of the People’s Republic of China. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
2211 Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Universal Health International Group Holding Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | HK$1.93 |
| 52 Week High | HK$2.47 |
| 52 Week Low | HK$0.76 |
| Beta | -0.71 |
| 1 Month Change | 9.04% |
| 3 Month Change | 28.67% |
| 1 Year Change | 56.91% |
| 3 Year Change | 83.81% |
| 5 Year Change | -56.14% |
| Change since IPO | -99.19% |
Recent News & Updates
We Discuss Why The CEO Of Universal Health International Group Holding Limited (HKG:2211) Is Due For A Pay Rise
Dec 04
Universal Health International Group Holding Limited's (HKG:2211) Shares Bounce 28% But Its Business Still Trails The Industry
Sep 25Recent updates
We Discuss Why The CEO Of Universal Health International Group Holding Limited (HKG:2211) Is Due For A Pay Rise
Dec 04Universal Health International Group Holding Limited's (HKG:2211) Shares Bounce 28% But Its Business Still Trails The Industry
Sep 25Improved Revenues Required Before Universal Health International Group Holding Limited (HKG:2211) Stock's 36% Jump Looks Justified
Jul 15There's No Escaping Universal Health International Group Holding Limited's (HKG:2211) Muted Revenues Despite A 42% Share Price Rise
May 26Universal Health International Group Holding (HKG:2211) Shareholders Should Be Cautious Despite Solid Earnings
Apr 04Universal Health International Group Holding Limited (HKG:2211) Stock Catapults 28% Though Its Price And Business Still Lag The Industry
Mar 06Universal Health International Group Holding Limited's (HKG:2211) Price Is Right But Growth Is Lacking After Shares Rocket 75%
Dec 18How Much Is Universal Health International Group Holding Limited (HKG:2211) CEO Getting Paid?
Jan 13
Shareholder Returns
| 2211 | HK Healthcare | HK Market | |
|---|---|---|---|
| 7D | 5.5% | -2.1% | 0.3% |
| 1Y | 56.9% | -15.5% | 32.2% |
Return vs Industry: 2211 exceeded the Hong Kong Healthcare industry which returned -15.5% over the past year.
Return vs Market: 2211 exceeded the Hong Kong Market which returned 32.2% over the past year.
Price Volatility
| 2211 volatility | |
|---|---|
| 2211 Average Weekly Movement | 6.5% |
| Healthcare Industry Average Movement | 6.0% |
| Market Average Movement | 6.6% |
| 10% most volatile stocks in HK Market | 14.4% |
| 10% least volatile stocks in HK Market | 3.0% |
Stable Share Price: 2211 has not had significant price volatility in the past 3 months compared to the Hong Kong market.
Volatility Over Time: 2211's weekly volatility has decreased from 17% to 7% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1998 | 842 | Chuanfu Chu | www.uhighl.com |
Universal Health International Group Holding Limited, an investment holding company, distributes and retails drugs and other pharmaceutical products in the northeastern region of the People’s Republic of China. It offers Chinese patent medicines, chemical preparations, antibiotics and biochemical drugs, traditional Chinese medicine decoction pieces, biological products, protein assimilation preparations, peptide hormones, disinfection products, blood products, medical equipment, prepackaged food, health care products, nutritional food, stereotyped packaging cosmetics, and daily necessities, as well as family planning supplies, such as contraceptives and utensils; and dairy products, including infant formula milk powder. The company also provides storage services.
Universal Health International Group Holding Limited Fundamentals Summary
| 2211 fundamental statistics | |
|---|---|
| Market cap | HK$213.35m |
| Earnings (TTM) | -HK$28.63m |
| Revenue (TTM) | HK$783.38m |
Is 2211 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 2211 income statement (TTM) | |
|---|---|
| Revenue | CN¥711.51m |
| Cost of Revenue | CN¥598.12m |
| Gross Profit | CN¥113.39m |
| Other Expenses | CN¥139.39m |
| Earnings | -CN¥26.01m |
Last Reported Earnings
Jun 30, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.24 |
| Gross Margin | 15.94% |
| Net Profit Margin | -3.66% |
| Debt/Equity Ratio | 7.9% |
How did 2211 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/12/06 06:32 |
| End of Day Share Price | 2025/12/05 00:00 |
| Earnings | 2025/06/30 |
| Annual Earnings | 2025/06/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Universal Health International Group Holding Limited is covered by 4 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Yue-Kwong Lui | CGS International |
| Manmohan Singh | CLSA |
| Bin Li | Morgan Stanley |